We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Scorpion Venom Could Serve as an Alternative to Morphine

By LabMedica International staff writers
Posted on 10 Mar 2010
Scorpion venom, a notorious poison, might be used as an alternative to dangerous and addictive painkillers such as morphine, according to a new study.

Researchers at Tel Aviv University (Israel), using an approach called rational design, are trying to develop a novel painkiller based on natural compounds found in the venom of the Israeli (family Buthidae) yellow scorpion--one of the most potent scorpions in the world--by mimicking the venom's bioactive components. More...
The scorpion venom contains more than 300 peptides, of which only a minor fraction has been explored. Among these are the alpha-neurotoxins, which target voltage-gated sodium channels (NA(V)S) and constitute an important component in the venom of the scorpions.

The NA(V)S toxins are short polypeptides highly conserved in sequence, and three-dimensional (3D) in structure, but they differ greatly in activity and preference for insects and various mammals. Despite extensive studies of the structure-function relationship of these toxins, little is known about their evolution and phylogeny. The researchers used a broad dataset based on published sequences and rigorous cloning to reconstruct a reliable phylogenetic tree of the scorpion alpha-toxins, and estimated the evolutionary forces involved in the diversification of their genes. They thus succeeded in isolating the genetic sequences for important neurotoxins in the scorpion venom, and also developed methods to produce and manipulate the toxins. The study describing the investigation process was published on December 17, 2009, in the early online edition of Molecular Biology and Evolution.

"The mammalian body has nine different sodium channels of which only a certain subtype delivers pain to our brain,” said lead author Professor Michael Gurevitz, Ph.D., of the department of plant sciences. "We are trying to understand how toxins in the venom interact with sodium channels at the molecular level and particularly how some of the toxins differentiate among channel subtypes.”

"This new class of drugs could be useful against serious burns and cuts, as well as in the military and in the aftermath of earthquakes and natural disasters,” added Professor Gurevitz. "Instead of running the risk of addiction, this venom-derived drug, mimicking the small peptide toxin, would do what it needs to do and then pass from the body with no traces or side-effects.”

The Israeli Buthidae yellow scorpion--Leiurus quinquestriatus--also known as the Omdurman scorpion or "deathstalker”--is regarded as a highly dangerous species because its venom is a powerful cocktail of neurotoxins. One component of the venom, the peptide chlorotoxin, has shown potential for treating human brain tumors. There has also been some evidence to show that other components of the venom may aid in the regulation of insulin, and could be used to treat diabetes.

Related Links:

Tel Aviv University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.